EP3562475A4 - Formulations de film mince de dérivés de 4-diphénylméthyl-1-pipérazine et de leurs sels - Google Patents

Formulations de film mince de dérivés de 4-diphénylméthyl-1-pipérazine et de leurs sels Download PDF

Info

Publication number
EP3562475A4
EP3562475A4 EP17889328.5A EP17889328A EP3562475A4 EP 3562475 A4 EP3562475 A4 EP 3562475A4 EP 17889328 A EP17889328 A EP 17889328A EP 3562475 A4 EP3562475 A4 EP 3562475A4
Authority
EP
European Patent Office
Prior art keywords
diphenylmethyl
salts
thin film
piperazine derivatives
film formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17889328.5A
Other languages
German (de)
English (en)
Other versions
EP3562475A1 (fr
Inventor
Anwar Siraj DAUD
Nidhi Prakash SAPKAL
Minal Nandkumar BONDE
Shikha BARVE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zim Laboratories Ltd
Original Assignee
Zim Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Laboratories Ltd filed Critical Zim Laboratories Ltd
Publication of EP3562475A1 publication Critical patent/EP3562475A1/fr
Publication of EP3562475A4 publication Critical patent/EP3562475A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP17889328.5A 2016-12-27 2017-12-22 Formulations de film mince de dérivés de 4-diphénylméthyl-1-pipérazine et de leurs sels Pending EP3562475A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201621044488 2016-12-27
PCT/IN2017/050613 WO2018122867A1 (fr) 2016-12-27 2017-12-22 Formulations de film mince de dérivés de 4-diphénylméthyl-1-pipérazine et de leurs sels

Publications (2)

Publication Number Publication Date
EP3562475A1 EP3562475A1 (fr) 2019-11-06
EP3562475A4 true EP3562475A4 (fr) 2020-07-01

Family

ID=62707074

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17889328.5A Pending EP3562475A4 (fr) 2016-12-27 2017-12-22 Formulations de film mince de dérivés de 4-diphénylméthyl-1-pipérazine et de leurs sels

Country Status (2)

Country Link
EP (1) EP3562475A4 (fr)
WO (1) WO2018122867A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108840417A (zh) * 2018-07-06 2018-11-20 佛山市陵谐环保科技有限公司 一种餐饮废水絮凝剂的制备方法
CN110726788B (zh) * 2019-11-15 2022-07-01 湖南九典制药股份有限公司 一种高效液相色谱法分离和测定盐酸左西替利嗪及其有关物质的方法
CN111821290A (zh) * 2020-02-27 2020-10-27 鲁南制药集团股份有限公司 一种盐酸西替利嗪有关物质的检测方法
CN114788809B (zh) * 2022-01-25 2023-04-14 江苏广承药业有限公司 一种氯雷他定液体制剂
CN114923965B (zh) * 2022-03-18 2023-05-23 杭州微策生物技术股份有限公司 一种一体式多指标传感器及其制作方法
CN117243927A (zh) * 2023-10-17 2023-12-19 深圳市泰力生物医药有限公司 含安全有效掩味剂的盐酸卡利拉嗪口溶膜制剂及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061700A2 (fr) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Compositions au gout masque et a desintegration rapide, et leurs procedes de preparation
US20100112050A1 (en) * 2008-11-03 2010-05-06 Je Phil Ryoo Dosage Form For Insertion Into The Mouth
DE102010049708A1 (de) * 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008119033A1 (fr) * 2007-03-27 2008-10-02 Eurand, Inc. Compositions pharmaceutiques comprenant une substance active issue de la famille des benzyhydrylpipérazines substituées
KR101407922B1 (ko) * 2013-11-14 2014-06-17 주식회사 서울제약 약리학적 활성 성분을 포함하는 다공성 구강붕해필름 및 이의 제조방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061700A2 (fr) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Compositions au gout masque et a desintegration rapide, et leurs procedes de preparation
US20100112050A1 (en) * 2008-11-03 2010-05-06 Je Phil Ryoo Dosage Form For Insertion Into The Mouth
DE102010049708A1 (de) * 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018122867A1 *

Also Published As

Publication number Publication date
EP3562475A1 (fr) 2019-11-06
WO2018122867A1 (fr) 2018-07-05

Similar Documents

Publication Publication Date Title
EP3562475A4 (fr) Formulations de film mince de dérivés de 4-diphénylméthyl-1-pipérazine et de leurs sels
EP3280461A4 (fr) Compositions de gel filmogène amovibles et leurs procédés d'application
EP3533444A4 (fr) Applications pharmaceutiques de la (s)-norkétamine et de ses sels
EP3509581A4 (fr) Formulations de (r
EP3548497A4 (fr) Polymorphes de sépiaptérine et leurs sels
EP3457851A4 (fr) Dérivés de sobétirome
EP3412660A4 (fr) Dérivé de sulfonamide et composition pharmaceutique le contenant
EP3381448A4 (fr) Film buccal hémostatique et de protection des plaies
EP3230486A4 (fr) Résistance à couche mince traitée par pulvérisation thermique et son procédé de fabrication
EP3202395A4 (fr) Film d'enrobage de capsule molle
EP3380525A4 (fr) Formulations pharmaceutiques et leurs procédés d'utilisation
EP3570826A4 (fr) Formulations de n-acétylcystéine et leurs utilisations
EP3408254A4 (fr) Sels de l'acide 5-aminolévulinique et dérivés
EP3490978A4 (fr) Sels de dérivés de 2, 6-diméthylpyrimidone et leurs utilisations
EP3524278A4 (fr) Film étirable et article le comprenant
EP3544967A4 (fr) Sels de dérivé d'indazole et leurs cristaux
EP3528787A4 (fr) Formulations pharmaceutiques et leurs procédés de préparation
EP3284775A4 (fr) Film étirable et produit le comprenant
EP3520770A4 (fr) Nouvelles applications de spermine et de dérivés de celle-ci
EP3520648A4 (fr) Couche mince et procédé de formation de couche mince
EP3445370A4 (fr) Procédés de préparation d'acide obéticholique et de dérivés de celui-ci
EP3448375A4 (fr) Dérivés de benzoylglycine et procédés de production et d'utilisation de ces dérivés
EP3456532A4 (fr) Film d'emballage médical
EP3452441A4 (fr) Dérivés d'acide alpha-truxillique et compositions pharmaceutiques associées
EP3506947A4 (fr) Formulations pharmaceutiques de régadénosone

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190726

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0009240000

Ipc: A61K0009700000

A4 Supplementary search report drawn up and despatched

Effective date: 20200604

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/495 20060101ALI20200528BHEP

Ipc: A61K 47/38 20060101ALI20200528BHEP

Ipc: C07D 295/03 20060101ALI20200528BHEP

Ipc: A61K 9/70 20060101AFI20200528BHEP

Ipc: A61K 47/32 20060101ALI20200528BHEP

Ipc: A61K 47/22 20060101ALI20200528BHEP

Ipc: A61P 37/08 20060101ALI20200528BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230202